RenovoRx RNXT
NASDAQ RNXT
$1.77 -0.23 (-11.32%)
As of: Sep 10, 2026 · 2:57 PM EDT

RenovoRx (RNXT) Net Margin Growth (1y) (2026)

Analysis

RenovoRx (RNXT) Net Margin Growth (1y) (2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Margin Growth (1y) (Qtr)
1 Abbott Laboratories 180.77 Bn 175.17 Bn 7.27 Bn -860.00
2 Intuitive Surgical 127.65 Bn 122.43 Bn 1.96 Bn 124.00
3 Medtronic 117.15 Bn 108.33 Bn 6.34 Bn 296.00
4 Stryker 104.21 Bn 100.73 Bn 4.50 Bn 469.00
5 Boston Scientific 63.46 Bn 62.92 Bn 3.85 Bn 92.00
6 Edwards Lifesciences 49.73 Bn 45.48 Bn 1.35 Bn -777.00
7 Alcon 33.01 Bn 31.56 Bn 1.68 Bn -
8 Dexcom 32.17 Bn 30.22 Bn 830.00 Mn 350.00
9 Steris 20.72 Bn 20.24 Bn 684.20 Mn 67.00
10 RenovoRx 84.43 Mn 84.43 Mn 766,000.00 24,455.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 24,455.00
Mar 31, 2026 91,670.00